{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:57:34Z","timestamp":1791140254922,"version":"4.1.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.revmed.2005.11.016","type":"journal-article","created":{"date-parts":[[2005,12,30]],"date-time":"2005-12-30T07:08:01Z","timestamp":1135926481000},"page":"313-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Maladie veineuse thromboembolique et\u00a0cancer"],"prefix":"10.1016","volume":"27","author":[{"given":"M.","family":"Pavic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Debourdeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Aletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Farge-Bancel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Rousset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2005.11.016_bib1","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/bmj.308.6933.891","article-title":"Deep venous thrombosis and occult malignancy: an epidemiological study","volume":"308","author":"Nordstrom","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.revmed.2005.11.016_bib2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.7326\/0003-4819-125-10-199611150-00001","article-title":"Importance of findings on the initial evaluation for cancer in patients with symptomatic idiopathic deep venous thrombosis","volume":"125","author":"Cornuz","year":"1996","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.revmed.2005.11.016_bib3","doi-asserted-by":"crossref","first-page":"556","DOI":"10.7326\/0003-4819-96-5-556","article-title":"Occult cancer in patients with acute pulmonary embolism","volume":"96","author":"Gore","year":"1982","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.revmed.2005.11.016_bib4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1001\/archinte.1987.00370020071039","article-title":"Occult malignant neoplasm in patients with deep venous thrombosis","volume":"147","author":"Goldberg","year":"1987","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.revmed.2005.11.016_bib5","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1001\/archinte.1987.00370110035004","article-title":"Deep venous thrombosis and pulmonary embolism. Risk of subsequent malignant neoplasms","volume":"147","author":"Griffin","year":"1987","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.revmed.2005.11.016_bib6","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJM199210153271604","article-title":"Deep-vein thrombosis and the incidence of subsequent symptomatic cancer","volume":"327","author":"Prandoni","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.revmed.2005.11.016_bib7","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1001\/archinte.165.15.1782","article-title":"Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults","volume":"165","author":"White","year":"2005","journal-title":"Arch. Intern Med."},{"key":"10.1016\/j.revmed.2005.11.016_bib8","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1056\/NEJM199804233381701","article-title":"The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism","volume":"338","author":"Sorensen","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.revmed.2005.11.016_bib9","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0140-6736(97)10018-6","article-title":"Venous thromboembolism and cancer","volume":"351","author":"Baron","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2005.11.016_bib10","doi-asserted-by":"crossref","first-page":"I17","DOI":"10.1161\/01.CIR.0000078466.72504.AC","article-title":"Venous thromboembolism and cancer: risks and outcomes","volume":"107","author":"Lee","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.revmed.2005.11.016_bib11","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1538-7836.2004.00720.x","article-title":"Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial","volume":"2","author":"Piccioli","year":"2004","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.revmed.2005.11.016_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1040-8428(03)00041-6","article-title":"Venous thromboembolism and cancer: new issues for an old topic","volume":"48","author":"Mandala","year":"2003","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.revmed.2005.11.016_bib13","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/bmj.323.7315.704","article-title":"Screening for cancer in venous thromboembolic disease","volume":"323","author":"Fennerty","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.revmed.2005.11.016_bib14","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S0140-6736(05)64210-9","article-title":"Occult cancer in patients with bilateral deep-vein thrombosis","volume":"350","author":"Rance","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2005.11.016_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0049-3848(03)00347-5","article-title":"Epidemiology and management of venous thromboembolism in patients with cancer","volume":"110","author":"Lee","year":"2003","journal-title":"Thromb. Res."},{"key":"10.1016\/j.revmed.2005.11.016_bib16","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archinte.160.6.809","article-title":"Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study","volume":"160","author":"Heit","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.revmed.2005.11.016_bib17","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00000441-195205000-00001","article-title":"Analysis of the autopsy records of 157 cases of carcinoma of the pancreas with particular reference to the incidence of thromboembolism","volume":"223","author":"Thompson","year":"1952","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.revmed.2005.11.016_bib18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/jso.2930280311","article-title":"Carcinoma of the gallbladder: autopsy findings in 287 cases and review of the literature","volume":"28","author":"Sons","year":"1985","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.revmed.2005.11.016_bib19","first-page":"607","article-title":"Thrombosis and malignancy: an underestimated problem","volume":"88","author":"Falanga","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.revmed.2005.11.016_bib20","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1136\/jcp.42.8.805","article-title":"Prevalence of pulmonary embolism at necropsy in patients with cancer","volume":"42","author":"Svendsen","year":"1989","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.revmed.2005.11.016_bib21","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1056\/NEJM198902233200802","article-title":"A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors","volume":"320","author":"Fisher","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.revmed.2005.11.016_bib22","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/jnci\/89.22.1673","article-title":"Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer","volume":"89","author":"Fisher","year":"1997","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.revmed.2005.11.016_bib23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1055\/s-2007-994915","article-title":"The thrombophilic state induced by therapeutic agents in the cancer patient","volume":"25","author":"Lee","year":"1999","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.revmed.2005.11.016_bib24","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00005792-199909000-00001","article-title":"Rates of initial and recurrent thromboembolic disease among patients with malignancy vs those without malignancy. Risk analysis using Medicare claims data","volume":"78","author":"Levitan","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2005.11.016_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-0038-1657515","article-title":"Prevention of thrombotic disorders in cancer patients undergoing chemotherapy","volume":"78","author":"Levine","year":"1997","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.revmed.2005.11.016_bib26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1055\/s-0037-1613051","article-title":"Venous thrombosis in patients with solid tumors: determination of frequency and characteristics","volume":"87","author":"Sallah","year":"2002","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.revmed.2005.11.016_bib27","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.293.6.715","article-title":"Malignancies, prothrombotic mutations, and the risk of venous thrombosis","volume":"293","author":"Blom","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.revmed.2005.11.016_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000046592","article-title":"Thromboprophylaxis in the cancer patient","volume":"106","author":"Thodiyil","year":"2001","journal-title":"Acta Haematol."},{"key":"10.1016\/j.revmed.2005.11.016_bib29","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0002-8703(96)90321-X","article-title":"Cancer and venous thromboembolism","volume":"132","author":"Piccioli","year":"1996","journal-title":"Am. Heart J."},{"key":"10.1016\/j.revmed.2005.11.016_bib30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1054\/blre.2001.0149","article-title":"Cancer and thrombosis revisited","volume":"15","author":"Hoffman","year":"2001","journal-title":"Blood Rev."},{"key":"10.1016\/j.revmed.2005.11.016_bib31","first-page":"331","article-title":"Effects of chemotherapeutic drugs on platelet and metastatic tumor cell-endothelial cell interactions as a model for assessing vascular endothelial integrity","volume":"45","author":"Nicolson","year":"1985","journal-title":"Cancer Res."},{"key":"10.1016\/j.revmed.2005.11.016_bib32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0305-7372(02)00044-0","article-title":"Cancer and thromboembolic disease: pathogenic mechanisms","volume":"28","author":"Lee","year":"2002","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.revmed.2005.11.016_bib33","first-page":"1767","article-title":"Maladie thromboembolique et cancer","volume":"23","author":"Meyer","year":"1994","journal-title":"Presse Med."},{"key":"10.1016\/j.revmed.2005.11.016_bib34","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1200\/JCO.1988.6.2.276","article-title":"Chemotherapy for breast cancer decreases plasma protein C and protein S","volume":"6","author":"Rogers","year":"1988","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.revmed.2005.11.016_bib35","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/1097-0142(19900215)65:4<885::AID-CNCR2820650410>3.0.CO;2-H","article-title":"Thrombogenicity of intravenous 5-fluorouracil alone or in combination with cisplatin","volume":"65","author":"Kuzel","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.revmed.2005.11.016_bib36","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/blood.V83.2.386.386","article-title":"Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in L'Asparaginase-induced antithrombin III deficiency","volume":"83","author":"Mitchell","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2005.11.016_bib37","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.amjmed.2004.03.040","article-title":"Adverse effects of thalidomide administration in patients with neoplastic diseases","volume":"117","author":"Dimopoulos","year":"2004","journal-title":"Am. J. Med."},{"key":"10.1016\/j.revmed.2005.11.016_bib38","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1200\/JCO.2002.20.6.1446","article-title":"Unexpected serious toxicity with chemotherapy and antiangiogenic combinations: time to take stock!","volume":"20","author":"Marx","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.revmed.2005.11.016_bib39","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.revmed.2004.06.012","article-title":"Traitement de la maladie thromboembolique veineuse chez les patients souffrant de cancers","volume":"25","author":"Levesque","year":"2004","journal-title":"Rev. Med. Intern."},{"key":"10.1016\/j.revmed.2005.11.016_bib40","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1056\/NEJM199603143341102","article-title":"Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman study group","volume":"334","author":"Koopman","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.revmed.2005.11.016_bib41","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJM199709043371001","article-title":"Low-molecular-weight heparin in the treatment of patients with venous thromboembolism","volume":"337","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.revmed.2005.11.016_bib42","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1200\/JCO.2000.18.17.3078","article-title":"Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis","volume":"18","author":"Hutten","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.revmed.2005.11.016_bib43","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0038-1648837","article-title":"Low molecular weight heparin vs warfarin in the prevention of recurrences after deep vein thrombosis","volume":"72","author":"Pini","year":"1994","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.revmed.2005.11.016_bib44","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s002689900081","article-title":"Low-molecular-weight heparin vs warfarin for prevention of recurrent venous thromboembolism: a randomized trial","volume":"20","author":"Das","year":"1996","journal-title":"World J. Surg."},{"key":"10.1016\/j.revmed.2005.11.016_bib45","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-0037-1614412","article-title":"Low molecular weight heparin vs acenocoumarol in the secondary prophylaxis of deep vein thrombosis","volume":"81","author":"Lopaciuk","year":"1999","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.revmed.2005.11.016_bib46","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/archinte.162.15.1729","article-title":"Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomised-controlled study","volume":"162","author":"Meyer","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.revmed.2005.11.016_bib47","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMoa025313","article-title":"Low-molecular-weight heparin vs a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer","volume":"349","author":"Lee","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.revmed.2005.11.016_bib48","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1001\/archinte.163.10.1243-a","article-title":"Is low-molecular-weight heparin safer than warfarin for secondary prevention of venous thromboembolism in cancer patients?","volume":"163","author":"Caine","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.revmed.2005.11.016_bib49","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0248-8663(03)00252-2","article-title":"Les nouveaux anticoagulants dans la maladie thromboembolique veineuse","volume":"24","author":"Bura-Riviere","year":"2003","journal-title":"Rev. Med. Interne"},{"key":"10.1016\/j.revmed.2005.11.016_bib50","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1200\/JCO.1996.14.2.652","article-title":"Inferior vena cava filters in cancer patients: indications and outcome","volume":"14","author":"Schwarz","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.revmed.2005.11.016_bib51","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0741-5214(98)70054-0","article-title":"Treatment of patients with venous thromboembolism and malignant disease: should vena cava filter placement be routine?","volume":"28","author":"Ihnat","year":"1998","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.revmed.2005.11.016_bib52","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1182\/blood.V95.12.3669.012k49_3669_3677","article-title":"Vena caval filters: a comprehensive review","volume":"95","author":"Streiff","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2005.11.016_bib53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1023\/B:THRO.0000014589.17314.24","article-title":"Cancer and thrombosis: mechanisms and treatment","volume":"16","author":"Deitcher","year":"2003","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.revmed.2005.11.016_bib54","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJM199802123380701","article-title":"A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Pr\u00e9vention du risque d'embolie pulmonaire par interruption cave study group","volume":"338","author":"Decousus","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.revmed.2005.11.016_bib55","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/CIRCULATIONAHA.104.512834","article-title":"Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (prevention du risque d'embolie pulmonaire par interruption cave) randomized study","volume":"112","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.revmed.2005.11.016_bib56","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1046\/j.1538-7836.2003.00275.x","article-title":"From Trousseau to targeted therapy: new insights and innovations in thrombosis and cancer","volume":"1","author":"Levine","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.revmed.2005.11.016_bib57","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1055\/s-2007-994925","article-title":"Prevention of venous thromboembolism in cancer patients","volume":"25","author":"Kakkar","year":"1999","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.revmed.2005.11.016_bib58","first-page":"45","article-title":"Prevention of fatal postoperative pulmonary embolism by low doses of heparin","volume":"2","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2005.11.016_bib59","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1046\/j.0007-1323.2001.01800.x","article-title":"Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery","volume":"88","author":"Mismetti","year":"2001","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.revmed.2005.11.016_bib60","doi-asserted-by":"crossref","first-page":"858","DOI":"10.7326\/0003-4819-135-10-200111200-00006","article-title":"Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review","volume":"135","author":"Hull","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.revmed.2005.11.016_bib61","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa012385","article-title":"Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer","volume":"346","author":"Bergqvist","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.revmed.2005.11.016_bib62","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0140-6736(94)90008-6","article-title":"Double-blind randomised trial of a very low-dose warfarin for prevention of thromboembolism in stage IV breast cancer","volume":"343","author":"Levine","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2005.11.016_bib63","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1200\/JCO.1995.13.1.42","article-title":"Very low-dose warfarin prophylaxis to prevent thromboembolism in women with metastatic breast cancer receiving chemotherapy: an economic evaluation","volume":"13","author":"Rajan","year":"1995","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.revmed.2005.11.016_bib64","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1200\/JCO.2003.02.042","article-title":"Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy?","volume":"21","author":"Masci","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.revmed.2005.11.016_bib65","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199909093411103","article-title":"A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in medical patients with enoxaparin study group","volume":"341","author":"Samama","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.revmed.2005.11.016_bib66","first-page":"298","article-title":"Thromboses veineuses sur cath\u00e9ters centraux en canc\u00e9rologie","volume":"30","author":"Gratadou","year":"2001","journal-title":"Presse Med."},{"key":"10.1016\/j.revmed.2005.11.016_bib67","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1634\/theoncologist.9-2-207","article-title":"Thrombotic complications of central venous catheters in cancer patients","volume":"9","author":"Kuter","year":"2004","journal-title":"Oncologist"},{"key":"10.1016\/j.revmed.2005.11.016_bib68","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/s-2007-994916","article-title":"Thrombotic complications of central venous catheters in cancer patients","volume":"25","author":"Bona","year":"1999","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.revmed.2005.11.016_bib69","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1148\/radiol.2203001181","article-title":"Catheter-related upper extremity deep venous thrombosis in cancer patients: a prospective study based on Doppler US","volume":"220","author":"Luciani","year":"2001","journal-title":"Radiology"},{"key":"10.1016\/j.revmed.2005.11.016_bib70","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.revmed.2004.11.017","article-title":"Thrombose symptomatique sur cath\u00e9ter veineux central de longue dur\u00e9e en oncologie\u00a0: un score de risque pr\u00e9dictif\u00a0?","volume":"26","author":"Morazin","year":"2005","journal-title":"Rev. Med. Interne"},{"key":"10.1016\/j.revmed.2005.11.016_bib71","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1161\/01.CIR.0000031705.57473.1C","article-title":"Upper-extremity deep vein thrombosis","volume":"106","author":"Joffe","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.revmed.2005.11.016_bib72","doi-asserted-by":"crossref","first-page":"423","DOI":"10.7326\/0003-4819-76-3-112-6-423","article-title":"Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial","volume":"112","author":"Bern","year":"1990","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.revmed.2005.11.016_bib73","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/s-0038-1650254","article-title":"Upper extremity deep venous thrombosis in cancer patients with venous access devices prophylaxis with a low molecular weight heparin (Fragmin)","volume":"75","author":"Monreal","year":"1996","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.revmed.2005.11.016_bib74","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0049-3848(03)00099-9","article-title":"An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial","volume":"109","author":"Massicotte","year":"2003","journal-title":"Thromb. Res."},{"key":"10.1016\/j.revmed.2005.11.016_bib75","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1200\/JCO.2005.10.192","article-title":"Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer","volume":"23","author":"Couban","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.revmed.2005.11.016_bib76","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1200\/JCO.2005.06.084","article-title":"Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients","volume":"23","author":"Verso","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.revmed.2005.11.016_bib77","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1200\/JCO.2005.03.133","article-title":"Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism","volume":"23","author":"Lee","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.revmed.2005.11.016_bib78","first-page":"677","article-title":"Venous thrombosis during multimodal treatment of primary breast carcinoma","volume":"65","author":"Weiss","year":"1981","journal-title":"Cancer Treat. Rep."},{"key":"10.1016\/j.revmed.2005.11.016_bib79","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/1097-0142(19841001)54:7<1264::AID-CNCR2820540706>3.0.CO;2-R","article-title":"Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients","volume":"54","author":"Goodnough","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/j.revmed.2005.11.016_bib80","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1056\/NEJM198802183180703","article-title":"The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer","volume":"318","author":"Levine","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.revmed.2005.11.016_bib81","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1200\/JCO.1991.9.2.286","article-title":"Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer","volume":"9","author":"Saphner","year":"1991","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.revmed.2005.11.016_bib82","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0002-9610(70)80023-X","article-title":"Deep vein thrombosis of the leg. Is there a \"high-risk\" group?","volume":"120","author":"Kakkar","year":"1970","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.revmed.2005.11.016_bib83","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1471-0528.1974.tb00466.x","article-title":"A study of pulmonary embolism and deep leg vein thrombosis after major gynaecological surgery using labelled fibrinogen-phlebography and lung scanning","volume":"81","author":"Walsh","year":"1974","journal-title":"J. Obstet. Gynaecol. Br. Commonw."},{"key":"10.1016\/j.revmed.2005.11.016_bib84","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/bmj.1.5959.649","article-title":"Prophylaxis of postoperative leg vine thrombosis by low dose subcutaneous heparin or peroperative calf muscle stimulation: a controlled clinical trial","volume":"1","author":"Rosenberg","year":"1975","journal-title":"BMJ"},{"key":"10.1016\/j.revmed.2005.11.016_bib85","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(86)91158-X","article-title":"Preoperative identification of patients at high-risk of deep venous thrombosis after elective major abdominal surgery","volume":"1","author":"Sue-Ling","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2005.11.016_bib86","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/bjs.1800700311","article-title":"The use of graduated compression stockings in the prevention of postoperative deep vein thrombosis","volume":"70","author":"Allan","year":"1983","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.revmed.2005.11.016_bib87","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1001\/jama.1984.03340460038022","article-title":"Dihydroergotamine-heparin prophylaxis of postoperative deep vein thrombosis. A multicenter trial","volume":"251","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.revmed.2005.11.016_bib88","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1001\/archsurg.1992.01420030076014","article-title":"Postoperative pulmonary embolism after hospital discharge. An underestimated risk","volume":"127","author":"Huber","year":"1992","journal-title":"Arch. Surg."}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866305005345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866305005345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:19:08Z","timestamp":1759335548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866305005345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":88,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0248866305005345"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2005.11.016","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maladie veineuse thromboembolique et\u00a0cancer","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2005.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}